Thyroglobulin Autoantibody - RIA

Lorenz 2.0 mm titanium system for the midface provides an excellent alternative to lower profile systems in areas of the midface where greater fixation is needed.

The Neuroclip is designed for safe, quick, and stable fixation of cranial bone flaps. Application is simple with minimal instrumentation. The Neuroclip can be applied to the cranial bone flap while t

Lorenz 1.0 mm titanium system provides a rigid fixation alternative for areas with high palpability and prominent bone formation. These areas include the frontal bone and the areas surrounding the or

1.0 mm Micro System. The Titanium Micro System is also useful in the practice of ENT, Neurosurgery and Handsurgery.

(Date:10/7/2008)...RNewswire-FirstCall/ -- Stallergenes S.A.,today an...greement with,Catalent for the promotion and distr...FLEX(R), co-developed and co-manufactured by Catal...sts of a syringe pre-filled with adrenaline, which....3 and 0.15 mg), in an,autoinjector device. The Me...

(Date:10/7/2008)...of asthma in a young child may well be more challe..., according to a review of research and clinical e... Indiana University School of Medicine and Riley H... issue of Clinical Pediatrics . , "Wheezing ca... Professor of Pediatrics at the IU School of Medic...

(Date:10/7/2008)...rial Specialties, Mfg. is pleased to announce the ...hese filters are exclusively available from Indust... push-to-connect style fittings integrated into th...ne filter offers versatility and customization for... (PRWEB) October 7, 2008 -- Exclusively availa...

(Date:10/6/2008)...fight against childhood obesity, researcher notes ... Three-quarters of middle schools have vending mac...new study finds. , The research demonstrates th...ls, and "that those vending machines don,t always ...y Virus, a registered dietitian with the Center fo...

India, Pakistan Teams To Inaugurate Inzy's Hospital

... been found through an animal study that Aspartame...ut that drinking four to five 20-ounce bottles of ...be the //cause of cancers. The study would be pub...ironmental Health Perspectives, an US government-r...

...East Asia has been long considered a wonderland fo...otel lobbies or restaurants without any inhibition...vernment is seriously thinking about imposing a sm...bars. In Malaysia and Thailand, smoking bans alre...

...attempting to learn a new task, taking short break...easy, according to a new study conducted by Massac...d Foster and Matthew Wilson, working at the Massac...bridge, found that rats' brains 'replay' their exp...

(Date:10/6/2008)...October 7 /-,Sosei Group Co...ectura,Group plc ("Vectura"; LSE: VEC), announce r...cacy, safety and tolerability of NVA237 presented ... Society (ERS) in Berlin,Germany. The new data sh...nhaled long-acting muscarinic antagonist (LAMA), p...

(Date:10/6/2008)...wswire/ -- "A return to the use of,chimpanzees in ...cientific,justification," according to a paper rel...ory Animals (ATLA). "An Assessment of the Role of,...at vaccine responses in,chimpanzees are not predic...impanzees, critical role and importance in AIDS va...

(Date:10/6/2008)... children, parents discussing clinical ...6 /PRNewswire-USNewswire/ -- From asthma and cance...es lives and improves their,health and well-being....alth (NIH), "Children and Clinical Studies", (http... offers parents and health,care providers an insid...

(Date:10/6/2008)...with Durezol Dosed Prior to Surgery, TAMPA, Fla.,... a,privately held ophthalmic-focused biopharmaceut...fluprednate ophthalmic emulsion) 0.05% is now,comm... the U.S. Food and,Drug Administration in June 200...d for the treatment of inflammation and pain assoc...

...WIRE)--Jul 2, 2007 - ViaCell, Inc.,(NASDAQ: VIAC) ...hief Executive Officer of ViaCell, will present an...eline at the C.E. Unterberg,Towbin Emerging Growt...07 at 3:00 p.m. at the Mandarin Oriental Hotel in ...tion will be available on,the Investor Information...

..., July 10, 2007 /CNW/ - Protox,Therapeutics Inc. (...lts from its Phase 1 clinical trial evaluating ,PR...e cancer,following radiation failure. The trial r...rated and shows promising signs,of therapeutic act...t. , ,"The completion of the PRX302 Phase 1 ...